These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27339942)

  • 1. Immune signaling-based Cascade Propagation approach re-stratifies HNSCC patients.
    Liu K; Chyr J; Zhao W; Zhou X
    Methods; 2016 Dec; 111():72-79. PubMed ID: 27339942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative Multiomics Analyses Identify Molecular Subtypes of Head and Neck Squamous Cell Carcinoma with Distinct Therapeutic Vulnerabilities.
    Diao P; Dai Y; Wang A; Bu X; Wang Z; Li J; Wu Y; Jiang H; Wang Y; Cheng J
    Cancer Res; 2024 Sep; 84(18):3101-3117. PubMed ID: 38959352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell genomics and immunosuppressive biomarker expression influence PD-L1 immunotherapy treatment responses in HNSCC-a computational study.
    Bates AM; Lanzel EA; Qian F; Abbasi T; Vali S; Brogden KA
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Aug; 124(2):157-164. PubMed ID: 28756882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
    Namani A; Matiur Rahaman M; Chen M; Tang X
    BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Cell Abundance and T-cell Receptor Landscapes Suggest New Patient Stratification Strategies in Head and Neck Squamous Cell Carcinoma.
    Secrier M; McGrath L; Ng F; Gulati S; Raymond A; Nuttall BRB; Berthe J; Jones EV; Sidders BS; Galon J; Barrett JC; Angell HK
    Cancer Res Commun; 2023 Oct; 3(10):2133-2145. PubMed ID: 37819239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head and neck cancer subtypes with biological and clinical relevance: Meta-analysis of gene-expression data.
    De Cecco L; Nicolau M; Giannoccaro M; Daidone MG; Bossi P; Locati L; Licitra L; Canevari S
    Oncotarget; 2015 Apr; 6(11):9627-42. PubMed ID: 25821127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of adenosine A2A receptor enhances CD8
    Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
    Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of genomic mutations associated with clinical outcomes of induction chemotherapy in patients with head and neck squamous cell carcinoma.
    Ock CY; Son B; Keam B; Lee SY; Moon J; Kwak H; Kim S; Kim TM; Jeon YK; Kwon SK; Hah JH; Lee SH; Kwon TK; Kim DW; Wu HG; Sung MW; Heo DS
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):873-83. PubMed ID: 26677030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploiting high-throughput cell line drug screening studies to identify candidate therapeutic agents in head and neck cancer.
    Nichols AC; Black M; Yoo J; Pinto N; Fernandes A; Haibe-Kains B; Boutros PC; Barrett JW
    BMC Pharmacol Toxicol; 2014 Nov; 15():66. PubMed ID: 25428177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative analysis of the microRNA-mRNA response to radiochemotherapy in primary head and neck squamous cell carcinoma cells.
    Summerer I; Hess J; Pitea A; Unger K; Hieber L; Selmansberger M; Lauber K; Zitzelsberger H
    BMC Genomics; 2015 Sep; 16(1):654. PubMed ID: 26328888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating genomics in head and neck cancer treatment: Promises and pitfalls.
    Thariat J; Vignot S; Lapierre A; Falk AT; Guigay J; Van Obberghen-Schilling E; Milano G
    Crit Rev Oncol Hematol; 2015 Sep; 95(3):397-406. PubMed ID: 25979769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mutations of PIK3CA gene in head and neck squamous cell carcinoma.
    Al-Amri AM; Vatte C; Cyrus C; Chathoth S; Hashim TM; Mohamed YS; Al Ali R; Alsaid A; Al Ali A
    Cancer Biomark; 2016; 16(3):377-83. PubMed ID: 26889984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subpath analysis of each subtype of head and neck cancer based on the regulatory relationship between miRNAs and biological pathways.
    An F; Zhang Z; Xia M; Xing L
    Oncol Rep; 2015 Oct; 34(4):1745-54. PubMed ID: 26239836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA traits linked to development of head and neck squamous cell carcinoma affect the progression-free survival of patients.
    Wichmann G; Herchenhahn C; Boehm A; Mozet C; Hofer M; Fischer M; Kolb M; Dietz A
    Oral Oncol; 2017 Jun; 69():115-127. PubMed ID: 28559015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting miRNA targets for head and neck squamous cell carcinoma using an ensemble method.
    Gao H; Jin H; Li G
    Int J Biol Markers; 2018 Jan; 33(1):87-93. PubMed ID: 28665450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-modality analysis supports APOBEC as a major source of mutations in head and neck squamous cell carcinoma.
    Faden DL; Thomas S; Cantalupo PG; Agrawal N; Myers J; DeRisi J
    Oral Oncol; 2017 Nov; 74():8-14. PubMed ID: 29103756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative computational analysis of transcriptional and epigenetic alterations implicates DTX1 as a putative tumor suppressor gene in HNSCC.
    Gaykalova DA; Zizkova V; Guo T; Tiscareno I; Wei Y; Vatapalli R; Hennessey PT; Ahn J; Danilova L; Khan Z; Bishop JA; Gutkind JS; Koch WM; Westra WH; Fertig EJ; Ochs MF; Califano JA
    Oncotarget; 2017 Feb; 8(9):15349-15363. PubMed ID: 28146432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Expression Signatures for Head and Neck Cancer Patient Stratification: Are Results Ready for Clinical Application?
    Tonella L; Giannoccaro M; Alfieri S; Canevari S; De Cecco L
    Curr Treat Options Oncol; 2017 May; 18(5):32. PubMed ID: 28474265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy.
    Uribe P; Gonzalez S
    Pathol Res Pract; 2011 Jun; 207(6):337-42. PubMed ID: 21531084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clusterization in head and neck squamous carcinomas based on lncRNA expression: molecular and clinical correlates.
    de Lena PG; Paz-Gallardo A; Paramio JM; García-Escudero R
    Clin Epigenetics; 2017; 9():36. PubMed ID: 28405244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.